- Report
- August 2022
United States
From €1766EUR$1,940USD£1,514GBP
- Report
- August 2022
Global
From €719EUR$790USD£616GBP
- Report
- August 2021
Global
From €3631EUR$3,990USD£3,113GBP
- Report
- October 2023
- 300 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- October 2023
- 100 Pages
Africa
From €1820EUR$2,000USD£1,560GBP
- Report
- October 2023
- 80 Pages
United Kingdom
From €1365EUR$1,500USD£1,170GBP
From €1365EUR$1,500USD£1,170GBP
- Report
- October 2023
- 80 Pages
South Korea
From €1365EUR$1,500USD£1,170GBP
- Report
- October 2023
- 80 Pages
Saudi Arabia
From €1365EUR$1,500USD£1,170GBP
- Report
- October 2023
- 80 Pages
India
From €1365EUR$1,500USD£1,170GBP
- Report
- October 2023
- 80 Pages
Germany
From €1365EUR$1,500USD£1,170GBP
- Report
- October 2023
- 80 Pages
France
From €1365EUR$1,500USD£1,170GBP
- Report
- October 2023
- 80 Pages
China
From €1365EUR$1,500USD£1,170GBP
- Report
- March 2024
- 209 Pages
Global
€4546EUR$4,995USD£3,897GBP
- Report
- October 2023
- 96 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- July 2023
- 118 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- May 2022
- 48 Pages
Global
From €1820EUR$2,000USD£1,560GBP
- Report
- April 2022
- 37 Pages
Global
From €1820EUR$2,000USD£1,560GBP
- Report
- October 2023
- 80 Pages
Vietnam
From €1365EUR$1,500USD£1,170GBP
- Report
- October 2023
- 80 Pages
United States
From €1365EUR$1,500USD£1,170GBP

Gastroparesis Drug is a type of drug used to treat gastroparesis, a condition in which the stomach muscles are weakened and unable to properly move food through the digestive system. These drugs are used to reduce symptoms such as nausea, vomiting, bloating, and abdominal pain. Commonly prescribed drugs for gastroparesis include metoclopramide, domperidone, and erythromycin. Other drugs, such as prokinetics, may also be used to help improve gastric emptying.
Gastroparesis Drug is a part of the larger Gastrointestinal Drugs market, which includes drugs used to treat a variety of gastrointestinal conditions. These drugs are used to reduce symptoms, improve digestion, and prevent further complications. Commonly prescribed drugs in this market include antacids, proton pump inhibitors, and laxatives.
Some companies in the Gastroparesis Drug market include Novartis, GlaxoSmithKline, Pfizer, and Takeda. Other companies, such as Allergan, Merck, and AstraZeneca, also produce drugs for the treatment of gastroparesis. Show Less Read more